Chronic Plaque Psoriasis Global Market Report 2025

Description

Chronic plaque psoriasis is a long-lasting, inflammatory skin condition marked by the development of well-defined, raised, red patches covered with silvery-white scales. These plaques commonly appear on areas such as the scalp, elbows, knees, and lower back, though they can form anywhere on the body. It is an autoimmune disorder where the immune system accelerates the turnover of skin cells, causing them to accumulate on the surface.

The primary drug classes used for treating chronic plaque psoriasis include biologics and small-molecule drugs. Biologics are advanced medications derived from living organisms that specifically target components of the immune system to treat various conditions. These drugs are available in injectable, oral, and topical forms and are distributed through hospital pharmacies, online pharmacies, and retail pharmacies.

The chronic plaque psoriasis market research report is one of a series of new reports from The Business Research Company that provides chronic plaque psoriasis market statistics, including chronic plaque psoriasis industry global market size, regional shares, competitors with a chronic plaque psoriasis market share, detailed chronic plaque psoriasis market segments, market trends and opportunities, and any further data you may need to thrive in the chronic plaque psoriasis industry. This chronic plaque psoriasis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic plaque psoriasis market size has grown strongly in recent years. It will grow from $20.79 billion in 2024 to $22.32 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth observed during the historic period can be attributed to factors such as the increasing prevalence of psoriasis, a rise in co-morbidities, favorable reimbursement policies, higher consumption of alcohol and smoking, and the growing adoption of telemedicine.

The chronic plaque psoriasis market size is expected to see strong growth in the next few years. It will grow to $29.33 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth anticipated during the forecast period can be attributed to factors such as the rising or declining global prevalence of chronic plaque psoriasis (CPP), an increase in autoimmune diseases, growth in healthcare budgets, an aging population, and the growing demand for effective treatments. Key trends expected during this period include advancements in biologic treatments, the development of oral small molecule inhibitors, the integration of digital health technologies, the rise of personalized medicine, and the introduction of biosimilars.

The rising incidence of immune system dysfunction is expected to drive growth in the chronic plaque psoriasis market. Immune system dysfunction occurs when the immune system fails to function properly, resulting in a higher risk of infections, autoimmune diseases, and cancer. Contributing factors to this increase include genetic predispositions, environmental triggers, malnutrition, chronic stress, and the growing prevalence of autoimmune diseases and infections such as HIV. Chronic plaque psoriasis treatment is essential to manage immune system dysfunction, as the immune system erroneously causes an overproduction of skin cells, leading to inflammation and plaque formation. For example, in December 2022, the National Psoriasis Foundation, a US-based nonprofit organization, reported that more than 8 million Americans are affected by psoriasis, while globally, the condition impacts 125 million people, representing 2 to 3% of the world's population. As a result, the growing cases of immune system dysfunction are fueling the expansion of the chronic plaque psoriasis market.

Leading companies in the chronic plaque psoriasis market are concentrating on developing innovative treatments, such as IL-17A and IL-17F inhibitors, to make progress in treating chronic plaque psoriasis. These inhibitors are targeted biologic therapies that block the pro-inflammatory cytokines interleukin-17A and interleukin-17F, which play a role in the immune response, helping to reduce inflammation in autoimmune conditions such as chronic plaque psoriasis. For example, in October 2023, UCB S.A., a Belgium-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved BIMZELX (bimekizumab-bkzx) for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Bimekizumab is the first psoriasis treatment specifically designed to target and inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F), two crucial cytokines involved in inflammation. Its approval was based on data from three Phase 3 multicenter trials-BE READY, BE VIVID, and BE SURE-which evaluated its safety and efficacy in 1,480 patients with moderate to severe plaque psoriasis.

In October 2024, Organon, a US-based healthcare company, acquired Dermavant Sciences Ltd. for an undisclosed sum. This acquisition strengthens Organon's dermatology portfolio by adding VTAMA (tapinarof) Cream, 1%, an innovative dermatologic treatment. VTAMA Cream is a novel, nonbiologic, non-steroidal topical therapy that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of mild, moderate, and severe plaque psoriasis in adults. Dermavant Sciences Ltd. is a US-based company dedicated to developing and commercializing groundbreaking therapies in the field of immunodermatology.

Major players in the chronic plaque psoriasis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Biogen Inc., UCB S.A., Dr. Reddy's Laboratories, Innovent Biologics Inc., Dong-A ST Co. Ltd., Alumis GmbH Co KG, Zai Lab Limited, GC Cell Corporation, Affibody AB, Nimbus Therapeutics, Bio-Thera Solutions, Can-Fite Biopharma, Celgene Corporation, Kadmon Pharmaceuticals, Aldeyra Therapeutics Inc., and Arcutis Biotherapeutics.

North America was the largest region in the chronic plaque psoriasis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic plaque psoriasis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic plaque psoriasis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic plaque psoriasis market consists of revenues earned by entities by providing services such as medication delivery services, customized treatment plans, and genetic and biomarker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic plaque psoriasis market also includes sales of vitamin D analogues, combination topicals, phosphodiesterase-4 inhibitors, and janus kinase inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Plaque Psoriasis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic plaque psoriasis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic plaque psoriasis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic plaque psoriasis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Biologics; Small Molecule Drugs
2) By Route Of Administration: Injectable; Oral; Topical
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
Subsegments:
1) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors (IL-12, IL-23, IL-17, IL-22); T-Cell Inhibitors; Others
2) By Small Molecule Drugs: Phosphodiesterase 4 (PDE4) Inhibitors; Janus Kinase (JAK) Inhibitors; Retinoids; Others
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33656

1. Executive Summary

2. Chronic Plaque Psoriasis Market Characteristics

3. Chronic Plaque Psoriasis Market Trends And Strategies

4. Chronic Plaque Psoriasis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Chronic Plaque Psoriasis Growth Analysis And Strategic Analysis Framework

5.1. Global Chronic Plaque Psoriasis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chronic Plaque Psoriasis Market Growth Rate Analysis
5.4. Global Chronic Plaque Psoriasis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chronic Plaque Psoriasis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chronic Plaque Psoriasis Total Addressable Market (TAM)

6. Chronic Plaque Psoriasis Market Segmentation

6.1. Global Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics
Small Molecule Drugs
6.2. Global Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable
Oral
Topical
6.3. Global Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.4. Global Chronic Plaque Psoriasis Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tumor Necrosis Factor (TNF) Inhibitors
Interleukin Inhibitors (IL-12, IL-23, IL-17, IL-22)
T-Cell Inhibitors
Others
6.5. Global Chronic Plaque Psoriasis Market, Sub-Segmentation Of Small Molecule Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phosphodiesterase 4 (PDE4) Inhibitors
Janus Kinase (JAK) Inhibitors
Retinoids
Others

7. Chronic Plaque Psoriasis Market Regional And Country Analysis

7.1. Global Chronic Plaque Psoriasis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chronic Plaque Psoriasis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Plaque Psoriasis Market

8.1. Asia-Pacific Chronic Plaque Psoriasis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Plaque Psoriasis Market

9.1. China Chronic Plaque Psoriasis Market Overview
9.2. China Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Plaque Psoriasis Market

10.1. India Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Plaque Psoriasis Market

11.1. Japan Chronic Plaque Psoriasis Market Overview
11.2. Japan Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Plaque Psoriasis Market

12.1. Australia Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Plaque Psoriasis Market

13.1. Indonesia Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Plaque Psoriasis Market

14.1. South Korea Chronic Plaque Psoriasis Market Overview
14.2. South Korea Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Plaque Psoriasis Market

15.1. Western Europe Chronic Plaque Psoriasis Market Overview
15.2. Western Europe Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Plaque Psoriasis Market

16.1. UK Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Plaque Psoriasis Market

17.1. Germany Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Plaque Psoriasis Market

18.1. France Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Plaque Psoriasis Market

19.1. Italy Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Plaque Psoriasis Market

20.1. Spain Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Plaque Psoriasis Market

21.1. Eastern Europe Chronic Plaque Psoriasis Market Overview
21.2. Eastern Europe Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Plaque Psoriasis Market

22.1. Russia Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Plaque Psoriasis Market

23.1. North America Chronic Plaque Psoriasis Market Overview
23.2. North America Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Plaque Psoriasis Market

24.1. USA Chronic Plaque Psoriasis Market Overview
24.2. USA Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Plaque Psoriasis Market

25.1. Canada Chronic Plaque Psoriasis Market Overview
25.2. Canada Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Plaque Psoriasis Market

26.1. South America Chronic Plaque Psoriasis Market Overview
26.2. South America Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Plaque Psoriasis Market

27.1. Brazil Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Plaque Psoriasis Market

28.1. Middle East Chronic Plaque Psoriasis Market Overview
28.2. Middle East Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Plaque Psoriasis Market

29.1. Africa Chronic Plaque Psoriasis Market Overview
29.2. Africa Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Plaque Psoriasis Market Competitive Landscape And Company Profiles

30.1. Chronic Plaque Psoriasis Market Competitive Landscape
30.2. Chronic Plaque Psoriasis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Plaque Psoriasis Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Eli Lilly and Company
31.3. Amgen Inc.
31.4. Boehringer Ingelheim
31.5. Biogen Inc.
31.6. UCB S.A.
31.7. Dr. Reddy's Laboratories
31.8. Innovent Biologics Inc.
31.9. Dong-A ST Co. Ltd.
31.10. Alumis GmbH Co KG
31.11. Zai Lab Limited
31.12. GC Cell Corporation
31.13. Affibody AB
31.14. Nimbus Therapeutics
31.15. Bio-Thera Solutions

32. Global Chronic Plaque Psoriasis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Plaque Psoriasis Market

34. Recent Developments In The Chronic Plaque Psoriasis Market

35. Chronic Plaque Psoriasis Market High Potential Countries, Segments and Strategies

35.1 Chronic Plaque Psoriasis Market In 2029 - Countries Offering Most New Opportunities
35.2 Chronic Plaque Psoriasis Market In 2029 - Segments Offering Most New Opportunities
35.3 Chronic Plaque Psoriasis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer